目的：提升专业药房(DTP药房)执业药师专业能力水平，助力DTP药房健康有序发展。方法： 梳理国内外DTP药房产生的背景和发展状况，分析我国DTP药房特点和作用，提出DTP药房对执业药师专业能力的要求。结果：我国DTP药房以提供全周期专业化药学服务为特色，在处方外流、药品带量采购、“双通道”管理机制等政策的激励下，DTP药房面临重要发展机遇。结论：执业药师应不断提升专业的药学服务能力、书写药历和开展药物警戒能力、患者用药信息收集分析能力、全流程药品质量管理能力、沟通协调和人文关怀服务能力，以适应新形势下我国DTP药房发展需求，促进DTP药房为患者提供有价值的健康服务。
Objective: To improve the professional ability level of licensed pharmacists in Direct to Patient (DTP) pharmacies, and help DTP pharmacies to develop in a healthy and orderly way. Methods: By sorting out the background and development status of DTP pharmacies at home and abroad, analyzing the characteristics and functions of DTP pharmacies in China, this article propose the requirements of DTP pharmacies for the professional competence of licensed pharmacists. Results: DTP pharmacies in China were characterized by providing fullcycle professional pharmacy services. DTP pharmacies are facing important development opportunities, motivating by policies such as outfl ow of prescriptions, drug belt procurement, and "dual-channel" management mechanism. Conclusion: Licensed pharmacists should continuously improve professional pharmacy service capabilities, writing medication records and developing pharmacovigilance capabilities, patient medication information collection and analysis capabilities, full-process drug quality management capabilities, communication and coordination capabilities and humanistic care service capabilities to meet the development needs of DTP pharmacies in China under the new situation, and promote DTP pharmacies to provide patients with valuable health services.
[1] 杨显辉,张晓霞.我国DTP药房的SWOT分析及发展建议[J].中国药事,2015,29(3):329-332.
[2] 文毅,汪偌宁,郑鑫,等.DTP药房患者管理服务效果的真实世界研究[J].医学新知,2021,31(3):169-177.
[3] 陈一,丁锦希,陈烨,等.“双通道”框架下的DTP药房管理模式研究[J].世界临床药物,2021,42(9):725-733.
[4] 王喆元,罗鑫,叶真,等.我国DTP药房肿瘤药学服务能力现状调研[J].中国药房,2020,31(9):1132-1138.
[5] 李松.DTP药房:亟待“升级版”药师[J].中国药店,2019(10):58-59.
[6] 蒋蓉,王怡诺,祝晶京,等.美国专业药房质量管理体系及对我国双通道药店管理的启示[J].中国卫生事业管理,2022,39(3):185-189,220.
[7] 周翔,陈超然.我国DTP药房发展过程及原因分析[J].中国卫生产业,2019,16(19):191-193.
[8] 中共中央办公厅国务院办公厅关于深化审评审批制度改革鼓励药品医疗器械创新的意见[EB/OL].(2017-10-08)[2022-09-23].http://www.gov.cn/zhengce/2017-10/08/content_5230105.htm.
[9] 国家市场监督管理总局.药品注册管理办法[EB/OL].(2020-01-22)[2022-09-23].https://gkml.samr.gov.cn/nsjg/fgs/202003/t20200330_313670.html?afFfvuaSlo7F=1664158001839#.
[10] 国家医疗保障局.医保发〔2019〕67号关于做好当前药品价格管理工作的意见[EB/OL].(2019-12-06)[2022-07-21].http://www.nhsa.gov.cn/art/2019/12/6/art_37_2149.html.
[11] 国家医疗保障局,国家卫生健康委员会.医保发〔2021〕28号关于建立完善国家医保谈判药品“双通道”管理机制的指导意见[EB/OL].(2021-05-10)[2022-07-21].http://www.nhsa.gov.cn/art/2021/5/10/art_37_5023.html
[12] 严羽,陶群山,魏骅.深化医疗保障制度改革背景下我国DTP药房发展模式探究[J].广东药科大学学报,2021,37(6):35-40.
[13] 周人华.医药分开视角下我国DTP药房模式探究[J].医学食疗与健康,2020,18(15):204,212.
[14] 中国医药商业协会.零售药店经营特殊疾病药品服务规范[EB/OL].(2019-12-27)[2022-07-21].http://www.capc.org.cn/index.html/view-8cee42a19f054cc08d13e46b0d0f33b9-0a292a617ad64f47b12bb6128eae5e62.html.
[15] 药师药学服务胜任力评价标准(试行)[J].中国合理用药探索,2017,14(9):1-2.
